Frontlight ResearchEarly access
Trial site
Dr. med. Andreas Wilke Dr. med. Andrej Malazhavy und Detelin Lalev Denchev Fachaerzte Innere Medizin und Kardiologie Partnerschaft
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Heart failure11 trials
- Obesity3 trials
- Familial hypercholesterolaemia2 trials
- Coronary artery disease1 trial
- High blood pressure1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 24 trials
- Phase 42 trials
- Status
- Recruiting7 trials
- Completed6 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Amgen Inc.2 trials
- AstraZeneca2 trials
- Novartis Pharma AG2 trials
- Novo Nordisk A/S2 trials
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure7 recruiting
- Obesity2 recruiting
- High blood pressure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
A proof of concept and dose-finding study of XXB750 in patients with heart failure
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026